This blog is all about current FDA approved drugs to treat the hepatitis C virus (HCV) with a focus on treating HCV according to genotype, using information extracted from peer-reviewed journals, liver meetings/conferences, and interactive learning activities.
Risk Of Developing Liver Cancer After HCV Treatment
▼
Thursday, January 13, 2011
Treating Hepatitis C With Telaprevir/SVR Stats 2011
My friends are back discussing SVR treating with Telaprevir in combination with Pegylated interferon and Ribavirin.
No comments:
Post a Comment